Published on in Vol 1, No 1 (2020): Jan-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19583, first published .
No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19

No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19

No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19

Journals

  1. Shende P, Khanolkar B, Gaud R. Drug repurposing: new strategies for addressing COVID-19 outbreak. Expert Review of Anti-infective Therapy 2021;19(6):689 View
  2. Ofori S, Hung Y, Schwind J, Diallo K, Babatunde D, Nwaobi S, Hua X, Sullivan K, Cowling B, Chowell G, Fung I. Economic evaluations of interventions against influenza at workplaces: systematic review. Occupational Medicine 2022;72(2):70 View
  3. Varghese R, Digholkar G, Karsiya J, Salvi S, Shah J, Kumar D, Sharma R. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug Metabolism and Personalized Therapy 2023 View
  4. Varghese R, Digholkar G, Karsiya J, Salvi S, Shah J, Kumar D, Sharma R. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug Metabolism and Personalized Therapy 2024;38(4):295 View
  5. Nakamura S, Sato Y, Kobayashi T, Oya A, Fujie A, Matsumoto M, Nakamura M, Kanaji A, Miyamoto T. Bezafibrate attenuates immobilization-induced muscle atrophy in mice. Scientific Reports 2024;14(1) View